SAN DIEGO, CA–(Marketwire – Sep 29, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, has initiated dosing in its PEDigree clinical trial where iSONEPT is being investigated as a treatment for retinal … […]
SAN DIEGO, CA–(Marketwire – Sep 23, 2011) – Cytori Therapeutics (NASDAQ: CYTX) has entered into a Celution? System agreement with Apollo Hospitals, one of Asia’s largest private healthcare groups, to offer the technology initially at select cosmet… […]
SAN DIEGO, CA–(Marketwire – Sep 22, 2011) – Medistem Inc. (PINKSHEETS: MEDS) announced today approval from the FDA to initiate a dose-escalating clinical trial in patients with critical limb ischemia using its Endometrial Regenerative Cell (ERC) st… […]
SAN DIEGO, CA–(Marketwire – Sep 20, 2011) – True Diagnostics, Inc.T (www.TrueDiagnostics.com) announces the Company has received sFDA clearance for its TrueDXT Platform with its first test for TSH and expects shipments to China to begin before the e… […]
SAN DIEGO, CA–(Marketwire – Sep 12, 2011) – Cytori Therapeutics (NASDAQ: CYTX) amended its loan facility with GE Capital, Healthcare Financial Services, Oxford Finance Corporation and Silicon Valley Bank by extending the maturity date from June 201… […]
Copyright © 2026 Biotech Networks, LLC
